Neumora Therapeutics, Inc. (NMRA)
0.73
-0.02
(-2.67%)
USD |
NASDAQ |
Sep 18, 16:00
0.7219
-0.01
(-1.11%)
After-Hours: 20:00
Neumora Therapeutics Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.071M |
| December 31, 2025 | 42.65M |
| September 30, 2025 | 51.32M |
| June 30, 2025 | 30.40M |
| March 31, 2025 | 44.16M |
| December 31, 2024 | -98.80M |
| September 30, 2024 | 156.99M |
| June 30, 2024 | 21.26M |
| March 31, 2024 | -150.00M |
| December 31, 2023 | 13.68M |
| Date | Value |
|---|---|
| September 30, 2023 | 23.82M |
| June 30, 2023 | 24.08M |
| March 31, 2023 | 2.817M |
| December 31, 2022 | -8.03M |
| September 30, 2022 | 16.69M |
| June 30, 2022 | -91.07M |
| March 31, 2022 | -85.61M |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 0.027M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BioAge Labs, Inc. | -164.51M |
| LB Pharmaceuticals, Inc. | 0.089M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -39.97M |
| Cash from Financing (Quarterly) | 9.735M |
| Free Cash Flow | -180.96M |
| Free Cash Flow Per Share (Quarterly) | -0.2159 |
| Free Cash Flow to Equity (Quarterly) | -39.85M |
| Free Cash Flow to Firm (Quarterly) | -38.15M |
| Free Cash Flow Yield | -142.6% |